In terms of revenue, global oncology drugs market was valued at US$ 119 billion in 2020. The introduction and approval of anti-PD-1 agents’ nivolumab and pembrolizumab for NSCLC has bought a new era for the cancer industry. The global Oncology Drugs market research is an intelligence report announced by Absolute Markets Insights. The erudite market study provides insightful data...